Terms: = Kidney tumors AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Prognosis
16 results:
1. Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma.
Saggese P; Pandey A; Alcaraz M; Fung E; Hall A; Yanagawa J; Rodriguez EF; Grogan TR; Giurato G; Nassa G; Salvati A; Shirihai OS; Weisz A; Dubinett SM; Scafoglio C
Cancer Res; 2024 Jan; 84(2):305-327. PubMed ID: 37934116
[TBL] [Abstract] [Full Text] [Related]
2. RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and ezh2 stability.
Wu Y; Xu Z; Chen X; Fu G; Tian J; Jin B
Cancer Med; 2023 Oct; 12(19):19889-19903. PubMed ID: 37747077
[TBL] [Abstract] [Full Text] [Related]
3. Long noncoding RNA UFC1 acts as an oncogene via stimulating ezh2-induced inhibition of APC expression in renal cell carcinoma.
Wang J; Liu G
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):152-156. PubMed ID: 37329532
[TBL] [Abstract] [Full Text] [Related]
4. Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma.
Liu Y; Cheng X; Xi P; Zhang Z; Sun T; Gong B
BMC Urol; 2023 Apr; 23(1):54. PubMed ID: 37004005
[TBL] [Abstract] [Full Text] [Related]
5. DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma.
Zhu Y; Liu X; Wang Y; Pan Y; Han X; Peng B; Zhang X; Niu S; Wang H; Ye Q; Gu Y; Gao S
Cell Death Dis; 2022 May; 13(5):456. PubMed ID: 35562342
[TBL] [Abstract] [Full Text] [Related]
6. Mutant CDKN2A regulates P16/p14 expression by alternative splicing in renal cell carcinoma metastasis.
Sun Q; Chen S; Hou Y; Wen X; Teng X; Zhang H; Lai C; Lai M
Pathol Res Pract; 2021 Jul; 223():153453. PubMed ID: 34022680
[TBL] [Abstract] [Full Text] [Related]
7. Development and Clinical Validation of a Seven-Gene Prognostic Signature Based on Multiple Machine Learning Algorithms in kidney Cancer.
Tian M; Wang T; Wang P
Cell Transplant; 2021; 30():963689720969176. PubMed ID: 33626918
[TBL] [Abstract] [Full Text] [Related]
8. Integral Analysis of the RNA Binding Protein-associated Prognostic Model for Renal Cell Carcinoma.
Qin X; Liu Z; Yan K; Fang Z; Fan Y
Int J Med Sci; 2021; 18(4):953-963. PubMed ID: 33456353
[TBL] [Abstract] [Full Text] [Related]
9. High level of ezh2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma.
Eichenauer T; Simmendinger L; Fraune C; Mandelkow T; Blessin NC; Kluth M; Hube-Magg C; Möller K; Clauditz T; Weidemann S; Dahlem R; Fisch M; Riechardt S; Simon R; Sauter G; Büscheck F; Rink M
World J Urol; 2021 Feb; 39(2):481-490. PubMed ID: 32303902
[TBL] [Abstract] [Full Text] [Related]
10. Long non-coding RNA HOTTIP is upregulated in renal cell carcinoma and regulates cell growth and apoptosis by epigenetically silencing of LATS2.
Peng F; Shi X; Meng Y; Dong B; Xu G; Hou T; Shi Y; Liu T
Biomed Pharmacother; 2018 Sep; 105():1133-1140. PubMed ID: 30021349
[TBL] [Abstract] [Full Text] [Related]
11. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of YB1 and ezh2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.
Wang Y; Chen Y; Geng H; Qi C; Liu Y; Yue D
Tumour Biol; 2015 Sep; 36(9):7159-66. PubMed ID: 25877750
[TBL] [Abstract] [Full Text] [Related]
13. [Expressions of ezh2 and RUNX3 in renal cell carcinoma and their clinical significance].
Wang G; Qin W; Zheng J; Wei M; Zhou X; Wang H; Wen W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):82-4, 88. PubMed ID: 23294722
[TBL] [Abstract] [Full Text] [Related]
14. Enhancer of zeste homolog 2 (ezh2) expression is an independent prognostic factor in renal cell carcinoma.
Wagener N; Macher-Goeppinger S; Pritsch M; Hüsing J; Hoppe-Seyler K; Schirmacher P; Pfitzenmaier J; Haferkamp A; Hoppe-Seyler F; Hohenfellner M
BMC Cancer; 2010 Oct; 10():524. PubMed ID: 20920340
[TBL] [Abstract] [Full Text] [Related]
15. Expression profile of the polycomb group protein enhancer of Zeste homologue 2 and its prognostic relevance in renal cell carcinoma.
Hinz S; Weikert S; Magheli A; Hoffmann M; Engers R; Miller K; Kempkensteffen C
J Urol; 2009 Dec; 182(6):2920-5. PubMed ID: 19846140
[TBL] [Abstract] [Full Text] [Related]
16. Biomarker discovery in urogenital cancer.
Said J
Biomarkers; 2005 Nov; 10 Suppl 1():S83-6. PubMed ID: 16298916
[TBL] [Abstract] [Full Text] [Related]
